The Hydration Pharmaceuticals Company Ltd (HPC) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.606x

Based on the latest financial reports, The Hydration Pharmaceuticals Company Ltd (HPC) has a cash flow conversion efficiency ratio of -0.606x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.64 Million ≈ $-1.16 Million USD) by net assets (AU$2.71 Million ≈ $1.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See HPC cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

The Hydration Pharmaceuticals Company Ltd - Cash Flow Conversion Efficiency Trend (2018–2024)

This chart illustrates how The Hydration Pharmaceuticals Company Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

The Hydration Pharmaceuticals Company Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of The Hydration Pharmaceuticals Company Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Diamcor Mining
V:DMI
-0.005x
Gossan Resources Ltd
V:GSS
-0.099x
Value Management & Research AG
F:VMR1
0.239x
Asia Pacific Investama Tbk PT
JK:MYTX
-0.021x
Team Internet Group PLC
LSE:TIG
0.091x
Mpower Group Ltd
AU:MPR
0.069x
Jaxon Mining Inc
V:JAX
0.002x
EDESAL Holding SA
BA:EDLH
0.159x

Annual Cash Flow Conversion Efficiency for The Hydration Pharmaceuticals Company Ltd (2018–2024)

The table below shows the annual cash flow conversion efficiency of The Hydration Pharmaceuticals Company Ltd from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see how much is The Hydration Pharmaceuticals Company Lt worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 AU$2.74 Million
≈ $1.94 Million
AU$-3.02 Million
≈ $-2.14 Million
-1.101x -106.89%
2023-12-31 AU$-358.25K
≈ $-253.49K
AU$-5.73 Million
≈ $-4.05 Million
15.993x +752.93%
2022-12-31 AU$3.98 Million
≈ $2.82 Million
AU$-9.75 Million
≈ $-6.90 Million
-2.449x -301.06%
2021-12-31 AU$13.23 Million
≈ $9.36 Million
AU$-8.08 Million
≈ $-5.72 Million
-0.611x +68.33%
2020-12-31 AU$2.00 Million
≈ $1.42 Million
AU$-3.86 Million
≈ $-2.73 Million
-1.928x -69.48%
2019-12-31 AU$2.44 Million
≈ $1.73 Million
AU$-2.78 Million
≈ $-1.97 Million
-1.138x +43.84%
2018-12-31 AU$2.66 Million
≈ $1.88 Million
AU$-5.40 Million
≈ $-3.82 Million
-2.026x --

About The Hydration Pharmaceuticals Company Ltd

AU:HPC Australia Food Distribution
Market Cap
$1.22 Million
AU$1.72 Million AUD
Market Cap Rank
#30382 Global
#1786 in Australia
Share Price
AU$0.00
Change (1 day)
+0.00%
52-Week Range
AU$0.00 - AU$0.02
All Time High
AU$0.36
About

The Hydration Pharmaceuticals Company Limited, together with its subsidiaries, markets and sells a range of liquid, tablet, and powder healthy hydration products in Australia, Canada, and the United States. The company sells its products under the Hydralyte brand through retail stores and online. The Hydration Pharmaceuticals Company Limited was founded in 2001 and is based in Melbourne, Australi… Read more